|
DKC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.523900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.156500E-02 |
| Normal-vs-Stage2 |
1.233120E-04 |
| Normal-vs-Stage3 |
4.735600E-03 |
| Normal-vs-Stage4 |
7.855200E-01 |
| Stage1-vs-Stage2 |
2.309700E-02 |
| Stage1-vs-Stage3 |
2.564400E-01 |
| Stage1-vs-Stage4 |
1.539000E-01 |
| Stage2-vs-Stage3 |
3.134600E-01 |
| Stage2-vs-Stage4 |
1.383730E-02 |
| Stage3-vs-Stage4 |
6.192300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.841500E-03 |
| Normal-vs-AfricanAmerican |
4.181500E-02 |
| Normal-vs-Asian |
7.592600E-01 |
| Caucasian-vs-AfricanAmerican |
9.095800E-01 |
| Caucasian-vs-Asian |
2.755400E-01 |
| AfricanAmerican-vs-Asian |
4.543600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.697960E-02 |
| Normal-vs-Female |
2.006100E-02 |
| Male-vs-Female |
9.812200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.424300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.170080E-02 |
| Normal-vs-Age(61-80Yrs) |
9.441900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.461140E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.213400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.048600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.134800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.639000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.414230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.396000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.053000E-01 |
| Normal-vs-Grade 2 |
5.026300E-02 |
| Normal-vs-Grade 3 |
5.437700E-04 |
| Normal-vs-Grade 4 |
9.963000E-01 |
| Grade 1-vs-Grade 2 |
8.544600E-01 |
| Grade 1-vs-Grade 3 |
6.629400E-01 |
| Grade 1-vs-Grade 4 |
3.833800E-01 |
| Grade 2-vs-Grade 3 |
7.628200E-02 |
| Grade 2-vs-Grade 4 |
3.690200E-01 |
| Grade 3-vs-Grade 4 |
1.348230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.575200E-03 |
| Normal-vs-ccB subtype |
5.755700E-02 |
| ccA subtype-vs-ccB subtype |
5.412400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.482020E-02 |
| Normal-vs-N1 |
8.092800E-01 |
| N0-vs-N1 |
5.084200E-01 |
|
|
